BUSINESS COMBINATION AGREEMENT AND PLAN OF REORGANIZATION BY AND AMONG PHOENIX BIOTECH ACQUISITION CORP., PBCE MERGER SUB, INC. AND CERO THERAPEUTICS, INC. DATED AS OF JUNE 4, 2023Business Combination Agreement • June 5th, 2023 • Phoenix Biotech Acquisition Corp. • Blank checks • Delaware
Contract Type FiledJune 5th, 2023 Company Industry JurisdictionThis BUSINESS COMBINATION AGREEMENT AND PLAN OF REORGANIZATION (this “Agreement”), dated as of June 4, 2023, is made by and among Phoenix Biotech Acquisition Corp., a Delaware corporation (“SPAC”), PBCE Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and CERo Therapeutics, Inc., a Delaware corporation (the “Company”). SPAC, Merger Sub and the Company shall be referred to herein from time to time collectively as the “Parties” (and each a “Party”). Capitalized terms used herein have the meanings set forth in Section 1.1 and Section 1.2.
BUSINESS COMBINATION AGREEMENT BY AND AMONG PHOENIX BIOTECH ACQUISITION CORP., OM MERGER SUB, INC. AND INTRINSIC MEDICINE, INC. DATED AS OF OCTOBER 30, 2022Business Combination Agreement • October 31st, 2022 • Phoenix Biotech Acquisition Corp. • Blank checks • New York
Contract Type FiledOctober 31st, 2022 Company Industry JurisdictionThis BUSINESS COMBINATION AGREEMENT (this “Agreement”), dated as of October 30, 2022, is made by and among Phoenix Biotech Acquisition Corp., a Delaware corporation (“SPAC”), OM Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and Intrinsic Medicine, Inc., a Delaware corporation (the “Company”). SPAC, Merger Sub and the Company shall be referred to herein from time to time collectively as the “Parties” (and each a “Party”). Capitalized terms used herein have the meanings set forth in Section 1.1 and Section 1.2.